Combination drug: Tobradex®
Tobramycin is an “aminoglycoside” antibiotic used to treat infections caused by many different bacteria. Tobramycin is usually administered by intravenous (i.v.) infusion, intramuscular (i.m.) injection, or inhalation. Tobramycin is available in special preparations to treat eye infections, alone and in a combination product.
Summary of
Interactions with Vitamins, Herbs, and Foods
(for details about the summarized interactions, read the full article)
|
Calcium* Magnesium* Potassium* Vitamin K |
|
|
Bifidobacterium longum* Lactobacillus acidophilus* Lactobacillus casei* Saccharomyces boulardii* Saccharomyces cerevisiae* Vitamin K |
|
|
Saccharomyces boulardii* |
|
| Reduced drug absorption/bioavailability |
None known |
| Adverse interaction |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Minerals
Calcium, magnesium, and
potassium depletion requiring prolonged replacement were
reported in a child with tetany who had just completed a three-week course of i.v.
tobramycin.1 The authors suggest this may have been due to kidney damage related to
the drug. Seventeen patients with cancer developed calcium, magnesium, and potassium depletion
after treatment with aminoglycoside antibiotics, including tobramycin.2 The authors
suggested a possible potentiating action of tobramycin-induced mineral depletion by chemotherapy drugs, especially doxorubicin (Adriamycin®).
Until more is known, people receiving i.v. tobramycin should ask their doctor about monitoring calcium, magnesium, and potassium levels and the possibility of mineral replacement.
Probiotics
A common side effect of antibiotics is diarrhea, which
may be caused by the elimination of beneficial bacteria normally found in the colon.
Controlled studies have shown that taking probiotic microorganisms—such as
Lactobacillus casei, Lactobacillus acidophilus, Bifidobacterium longum,
or Saccharomyces boulardii—helps prevent antibiotic-induced
diarrhea.3
The diarrhea experienced by some people who take antibiotics also might be due to an overgrowth of the bacterium Clostridium difficile, which causes a disease known as pseudomembranous colitis. Controlled studies have shown that supplementation with harmless yeast—such as Saccharomyces boulardii4 or Saccharomyces cerevisiae (baker’s or brewer’s yeast)5 —helps prevent recurrence of this infection. In one study, taking 500 mg of Saccharomyces boulardii twice daily enhanced the effectiveness of the antibiotic vancomycin in preventing recurrent clostridium infection.6 Therefore, people taking antibiotics who later develop diarrhea might benefit from supplementing with saccharomyces organisms.
Treatment with antibiotics also commonly leads to an overgrowth of yeast (Candida albicans) in the vagina (candida vaginitis) and the intestines (sometimes referred to as “dysbiosis”). Controlled studies have shown that Lactobacillus acidophilus might prevent candida vaginitis.7
Vitamin K
Several cases of excessive bleeding have been reported in people who take
antibiotics.8 9 10 11 This side effect may be the
result of reduced vitamin K activity and/or reduced vitamin K production by bacteria in the
colon. One study showed that people who had taken broad-spectrum antibiotics had lower liver
concentrations of vitamin K2 (menaquinone), though vitamin K1 (phylloquinone) levels remained
normal.12 Several antibiotics appear to exert a strong effect on vitamin K
activity, while others may not have any effect. Therefore, one should refer to a specific
antibiotic for information on whether it interacts with vitamin K. Doctors of natural medicine
sometimes recommend vitamin K supplementation to people taking antibiotics. Additional
research is needed to determine whether the amount of vitamin K1 found in some multivitamins
is sufficient to prevent antibiotic-induced bleeding. Moreover, most multivitamins do not
contain vitamin K.
As with many antibiotics, tobramycin can deplete vitamin K.13 14 It makes sense for people taking tobramycin to supplement vitamin K to protect against drug-induced deficiency. Doctors sometimes suggest a daily intake between several hundred micrograms and one milligram.
1. Slayton W, Anstine D, Lakhdir F, et al. Tetany in a child with AIDS receiving intravenous tobramycin. South Med J 1996;89:1108–10.
2. Keating MJ, Sethi MR, Bodey GP, Samaan NA. Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer 1977;39:1410–4.
3. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996;275:870–6 [review].
4. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996;275:870–6 [review].
5. Schellenberg D, Bonington A, Champion CM, et al. Treatment of Clostridium difficile diarrhoea with brewer’s yeast. Lancet 1994;343:171–2.
6. Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterol 1989;96:981–8.
7. Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996;275:870–6 [review].
8. Suzuki K, Fukushima T, Meguro K, et al. Intracranial hemorrhage in an infant owing to vitamin K deficiency despite prophylaxis. Childs Nerv Syst 1999;15:292–4.
9. Huilgol VR, Markus SL, Vakil NB. Antibiotic-induced iatrogenic hemobilia. Am J Gastroenterol 1997;92:706–7.
10. Bandrowsky T, Vorono AA, Borris TJ, Marcantoni HW. Amoxicllin-related postextraction bleeding in an anticoagulated patient with tranexamic acid rinses. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:610–2.
11. Kaiser CW, McAuliffe JD, Barth RJ, Lynch JA. Hypoprothrombinemia and hemorrhage in a surgical patient treated with cefotetan. Arch Surg 1991;126:524–5.
12. Conly J, Stein K. Reduction of vitamin K2 concentration in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med 1994;17:531–9.
13. Rhodes EG, Harris RI, Welch RS, et al. Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef. J Hosp Infect 1987;9:278–84.
14. Baxter JG, Marble DA, Whitfield LR, et al. Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin. Ann Surg 1985;201:96–102.
Copyright © 2004 Healthnotes, Inc. All rights reserved. www.healthnotes.com
Please read the disclaimer about the limitations of the information provided here. Do NOT rely solely on the information in this article.
Learn more about Healthnotes, the company.
Learn more about the authors of Using Medicines with Vitamins and Herbs
The information presented in Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires March 2005.